Evidence map›Paper›PMID 31137568›Full record

ReviewCancers2019

Paralogous HOX13 Genes in Human Cancers.

Gerardo Botti, Clemente Cillo, Rossella De Cecio, Maria Gabriella Malzone, Monica Cantile

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Biomolecules & biomedicine · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gerardo BottiScientific Direction, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy. g.botti@istitutotumori.na.it.
Clemente CilloDepartment of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, 80131 Naples, Italy. clecillo@unina.it.
Rossella De CecioPathology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy. r.dececio@istitutotumori.na.it.
Maria Gabriella MalzonePathological Anatomy Laboratory, Casa di Cura Maria Rosaria, 80045 Pompei, Italy. gabriellamalzone@gmail.com.
Monica CantilePathology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy. m.cantile@istitutotumori.na.it.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hox genes (HOX in humans), an evolutionary preserved gene family, are key determinants of embryonic development and cell memory gene program. Hox genes are organized in four clusters on four chromosomal loci aligned in 13 paralogous groups based on sequence homology (Hox gene network). During development Hox genes are transcribed, according to the rule of "spatio-temporal collinearity", with early regulators of anterior body regions located at the 3' end of each Hox cluster and the later regulators of posterior body regions placed at the distal 5' end. The onset of 3' Hox gene activation is determined by Wingless-type MMTV integration site family (Wnt) signaling, whereas 5' Hox activation is due to paralogous group 13 genes, which act as posterior-inhibitors of more anterior Hox proteins (posterior prevalence). Deregulation of HOX genes is associated with developmental abnormalities and different human diseases. Paralogous HOX13 genes (HOX A13, HOX B13, HOX C13 and HOX D13) also play a relevant role in tumor development and progression. In this review, we will discuss the role of paralogous HOX13 genes regarding their regulatory mechanisms during carcinogenesis and tumor progression and their use as biomarkers for cancer diagnosis and treatment.

Indexed as

HOX gene networkparalogous HOX 13 genestumor diseases

Identifiers

PMID31137568
PMCPMC6562813
OpenAlexW2946549066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.